<?xml version="1.0" encoding="UTF-8"?>
<ref id="B134">
 <label>134.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Teo</surname>
    <given-names>KK</given-names>
   </name>
   <name>
    <surname>Goldstein</surname>
    <given-names>LB</given-names>
   </name>
   <name>
    <surname>Chaitman</surname>
    <given-names>BR</given-names>
   </name>
   <name>
    <surname>Grant</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Weintraub</surname>
    <given-names>WS</given-names>
   </name>
   <name>
    <surname>Anderson</surname>
    <given-names>DC</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Extended-release niacin therapy and risk of ischemic stroke in patients with cardiovascular disease: the atherothrombosis intervention in metabolic syndrome with low HDL/high triglycerides: impact on global health outcome (AIM-HIGH) trial</article-title>. 
  <source>Stroke</source>. (
  <year>2013</year>) 
  <volume>44</volume>:
  <fpage>2688</fpage>â€“
  <lpage>93</lpage>. 
  <pub-id pub-id-type="doi">10.1161/STROKEAHA.113.001529</pub-id>
  <?supplied-pmid 23881958?>
  <pub-id pub-id-type="pmid">23881958</pub-id>
 </mixed-citation>
</ref>
